Europe Health Technology Assessment Associate Lead

Role Overview

This position requires collaboration with regional access leads to identify and address evidence needs from Health Technology Assessment (HTA) stakeholders throughout Europe. You'll engage with internal cross-functional teams to collect and synthesize evidence for various EU HTA initiatives, including PICO surveys and data consolidation.

Key Responsibilities

• Develop market access strategies and clinical development plans for the oncology portfolio, emphasizing evidence requirements for European and Canadian HTA and payer stakeholders.
• Co-lead the preparation and submission of EU HTA documents, ensuring adherence to compliance guidelines and processes.
• Foster collaboration and promote organizational values while enhancing awareness of EU HTA evidence requirements among cross-functional, global, regional, and local partners.

Contribution Areas

• Assist in the creation of high-quality HTA submission dossiers for new oncology medicines in collaboration with the EUCAN Access Lead.
• Work alongside global and EUCAN PVA leads to ensure timely mapping of HTA and payer evidence requirements.
• Represent EU HTA evidence needs in internal forums while communicating updates regarding joint HTA guidelines.
• Co-lead scientific consultations to gather feedback on clinical trial strategies to enhance evidence generation plans.
• Act as the primary contact for all evidence-related topics concerning Joint Clinical Assessments and Joint Scientific Consultations for priority assets.
• Guide stakeholders on methodological requirements related to EU HTA regulations to supplement current product expertise.
• Keep abreast of EU HTA guidelines and communicate relevant updates to internal teams.
• Analyze trends and strategic insights regarding national HTAs and regulatory agencies to inform global PVA strategies.

Qualifications and Skills

Applicants should possess the following:

• A minimum bachelor’s degree; an advanced/graduate degree (MSc, PhD, MPH, MPP, MBA) is preferred.
• A minimum of 6 years of experience in the biopharmaceutical industry or healthcare consulting.
• At least 4 years in market access, health economics, pricing, health policy, outcomes research, or consultancy.
• A strong understanding of the EU payer and HTA landscape, including methodologies and reimbursement processes.
• Exceptional verbal and written communication skills, with the ability to influence and collaborate effectively across teams.
• Proven experience managing complex projects and navigating multi-stakeholder environments under pressure.
• A solid knowledge of drug development processes and familiarity with pharmaceutical cross-functional teamwork.
• Adept at managing ambiguity and complex trade-offs in discussions while providing strategic input into HTA submissions.
• Experience with health technology assessment tools, evidence synthesis approaches, and HTA/payer insights.

Preferred Qualifications

• An advanced/graduate degree (MSc, PhD, MPH, MPP, MBA) is preferred.
• A degree or diploma in health economics or economic evaluations.
• Previous experience in the oncology field.
• Experience in a regional or global role is advantageous.
• Prior involvement in national HTA submissions or interactions with HTA/regulatory agencies is a plus.

Travel Commitment

Expect approximately 20% of time dedicated to domestic and/or international travel.

Additional Considerations

• Experience in assessing evidence needs for major HTA/payer stakeholders within the EU5 or Canada is beneficial.
• Proven collaboration and communication capabilities, especially in matrix environments.
• A solution-oriented mindset with strong internal stakeholder management experience.
• Deep understanding of the clinical development process.